Novartis’ breast cancer drug cuts risk of death by 19 percent after six years, data shows

LONDON: Swiss drugmaker Novartis’ drug Kisqali helped extend survival for women with a form of high-risk, early-stage breast cancer, cutting their risk of death by 19 percent…

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.arabnews.com)